Neon Therapeutics, Inc. (NTGN): Price and Financial Metrics
NTGN Price/Volume Stats
| Current price | $3.07 | 52-week high | $6.25 |
| Prev. close | $2.84 | 52-week low | $0.88 |
| Day low | $2.92 | Volume | 3,609,700 |
| Day high | $3.09 | Avg. volume | 516,108 |
| 50-day MA | $2.26 | Dividend yield | N/A |
| 200-day MA | $2.00 | Market Cap | 88.93M |
NTGN Stock Price Chart Interactive Chart >
Neon Therapeutics, Inc. (NTGN) Company Bio
Neon Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in developing neoantigen-targeted therapies for cancers in the United States. It is developing NEO-PV-01, a neoantigen vaccine that is in Phase Ib clinical trial in combination with nivolumab for the treatment of metastatic melanoma, non-small cell lung cancer, and bladder cancer; NEO-PTC-01, a neoantigen T cell therapy for the treatment of solid tumors; and NEO-SV-01, a neoantigen vaccine for the treatment of estrogen-receptor-positive breast cancer. The company was founded in 2013 and is based in Cambridge, Massachusetts.
Latest NTGN News From Around the Web
Below are the latest news stories about Neon Therapeutics Inc that investors may wish to consider to help them evaluate NTGN as an investment opportunity.
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies – HXL, AMTD, FSB, NTGNNEW YORK, March 12, 2020 -- Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders.. |
Lifshitz & Miller LLP Announces Investigation of Neon Therapeutics, Inc., Stein Mart, Inc., and Taubman Centers, Inc.NEW YORK, March 11, 2020 -- Neon Therapeutics, Inc. (NASDAQ:NTGN) Lifshitz & Miller announces investigation into possible breach of fiduciary duties in connection with. |
Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - FSB, NTGN, HXLNEW YORK, NY / ACCESSWIRE / March 9, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ... |
MEET, AMTD, NTGN, and HXL SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of MergersWILMINGTON, Del., March 09, 2020 -- Rigrodsky & Long, P.A. announces that it is investigating: The Meet Group, Inc. (NASDAQ GS: MEET) regarding possible breaches of. |
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates Whether The Sale Of These Companies Is Fair To Shareholders - HXL, NTGN, AMTDNEW YORK, NY / ACCESSWIRE / March 4, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP ... |
NTGN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 33.48% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |
| 2019 | -76.54% |
Loading social stream, please wait...